Skip to main content
OpenTrials
Completed

NCT Number: NCT02860884

Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease

The main objective of this study is to evaluate the ability of infrared spectroscopy to discriminate simple hepatic steatosis from NASH

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fatty Liver Digestive System Diseases Liver Diseases Non-Alcoholic Fatty Liver Disease

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre hospitalier universitaire de Rennes

Rennes, 35033, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who have undergone a liver biopsy for simple fatty liver or NASH and for which a serum sample is serum bank
  • Men or Women
  • aged of 18 years or more
  • After giving their consent to participate in research

Exclusion criteria

  • Known Cancer
  • Refusal of consent
  • Inflammatory disease

Treatment and study plan

Liver biopsy

Procedure

infrared spectroscopy

Other

Primary outcomes

  1. Sensitivity

    Time frame: through study completion, an average of 1 year

    Evaluation of the ability of infrared spectroscopy to discriminate simple hepatic steatosis from NASH with liver biopsy as a gold standard

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Registry information

Acronym: NASH

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Aug 9, 2016
Registry last updated
Aug 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.